Cost of managing anemia in end-stage renal disease: the experience of five French dialysis centers

Jacques Rottembourg (), Patrick Tilleul, Gilbert Deray, Antoine Lafuma, Lorraine Zakin, Lamine Mahi and Jorge Wernli

The European Journal of Health Economics, 2015, vol. 16, issue 4, 357-364

Abstract: The main factors that were predictive of 1-year cost of anemia treatment in hemodialysis patients were centers, patients in the Low Hb category, and dialysis duration of less than 2 years. Copyright Springer-Verlag Berlin Heidelberg 2015

Keywords: Anemia; Hemodialysis; Erythropoiesis-stimulating agents; Intravenous iron; Transfusion; Health economics; H51; I1 (search for similar items in EconPapers)
Date: 2015
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://hdl.handle.net/10.1007/s10198-014-0571-y (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:eujhec:v:16:y:2015:i:4:p:357-364

Ordering information: This journal article can be ordered from
http://www.springer. ... cs/journal/10198/PS2

DOI: 10.1007/s10198-014-0571-y

Access Statistics for this article

The European Journal of Health Economics is currently edited by J.-M.G.v.d. Schulenburg

More articles in The European Journal of Health Economics from Springer, Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ) Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().